Skip to main content
. 2025 Sep 18;13(3):200. doi: 10.3390/medsci13030200
ALK Anaplastic lymphoma kinase
BBB Blood–brain barrier
BMs Brain metastases
CNS Central nervous system
DCR Disease control rate
EGFR Epidermal growth factor receptor
IC-ORR Intracranial objective response rates
iDCR Intracranial disease control rate
iORR Intracranial objective response rate
iPFS Intracranial progression-free survival
NSCLC Non-small cell lung cancer
OS Overall survival
PFS Progression-free survival
SRS Stereotactic radiosurgery
TKIs Tyrosine kinase inhibitors